These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27013809)

  • 1. Serum Total Sialic Acid and Highly Sensitive C-reactive Protein: Prognostic Markers for the Diabetic Nephropathy.
    Varma V; Varma M; Varma A; Kumar R; Bharosay A; Vyas S
    J Lab Physicians; 2016; 8(1):25-9. PubMed ID: 27013809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study of High Sensitivity C-Reactive Protein and Metabolic Variables in Type 2 Diabetes Mellitus with and without Nephropathy.
    Shaheer AK; Tharayil JK; Krishna PW
    J Clin Diagn Res; 2017 Sep; 11(9):BC01-BC04. PubMed ID: 29207691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL; Wu J; Guo LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy.
    Shivananda Nayak B; Duncan H; Lalloo S; Maraj K; Matmungal V; Matthews F; Prajapati B; Samuel R; Sylvester P
    Vasc Health Risk Manag; 2008; 4(1):243-7. PubMed ID: 18629366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications.
    Nayak BS; Roberts L
    J Inflamm (Lond); 2006 Dec; 3():17. PubMed ID: 17187674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients.
    Shelbaya S; Amer H; Seddik S; Allah AA; Sabry IM; Mohamed T; El Mosely M
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):176-82. PubMed ID: 22428468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of serum sialic Acid in type-2 diabetes mellitus and its complication (nephropathy).
    K P; Kumar J A; Rai S; Shetty SK; Rai T; Shrinidhi ; Begum M; Md S
    J Clin Diagn Res; 2013 Nov; 7(11):2435-7. PubMed ID: 24392365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Serum Total Bilirubin Concentration was Associated with Increased High Sensitive C Reactive Protein Level in Patients with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus Subjects.
    Zheng J; Wu Y; Li Z; Wang H; Xiao W; Shi Y; Wang T
    Clin Lab; 2016; 62(5):901-7. PubMed ID: 27349017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus.
    Ekin S; Mert N; Gunduz H; Meral I
    Biol Trace Elem Res; 2003 Sep; 94(3):193-201. PubMed ID: 12972687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
    Yang SP; Gong CX; Cao BY; Yan C
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between interleukin-19 concentration and diabetic nephropathy.
    Li L; Jiang XG; Hu JY; Yu ZQ; Xu JY; Liu F; Zhao GC; Zhang L; Gu HM; Zhang SJ; Meng J
    BMC Nephrol; 2017 Feb; 18(1):65. PubMed ID: 28201997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between serum uric acid levels and high sensitive C-reactive protein in patients with type 2 diabetes].
    Li ZY; Liu B; Ji Y; Zhuang XJ; Shen YD; Tian HR; Li LX; Liu F
    Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(28):2181-2185. PubMed ID: 28763896
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure.
    Rajendiran KS; Ananthanarayanan RH; Satheesh S; Rajappa M
    Br J Biomed Sci; 2014; 71(1):29-32. PubMed ID: 24693572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein level following treatment and withdrawal of lovastatin in diabetic nephropathy.
    Rashtchizadeh N; Argani H; Ghorbanihaghjo A; Nezami N; Safa J; Montazer-Saheb S
    Iran J Kidney Dis; 2009 Apr; 3(2):93-8. PubMed ID: 19395785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
    Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
    Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum high-sensitivity C-reactive protein is not increased in patients with IgA nephropathy.
    Baek JE; Chang JW; Min WK; Cho YM; Park JS; Kim SB
    Nephron Clin Pract; 2008; 108(1):c35-40. PubMed ID: 18087170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.